New Products
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib，也称为 PK-10571 和 GB002，是一种新型吸入性 Pdgfr 激酶抑 | ||||
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat 是一种口服的、不可逆的赖氨酸特异性去甲基酶 1 (LSD1) | ||||
| 51614 | AMG-925 | 1401033-86-0 | 98% |  |
| AMG-925 is a potent and orally bioavailable dual inhibitor of CDK4 and FLT3, includin | ||||
| 102703 | AZD-8835 | 1620576-64-8 | ≧98.0% |  |
| AZD8835 is a potent and selective inhibitor ofPI3KαandPI3KδwithIC50s of 6.2 and 5.7 | ||||
| 611902 | PF-04979064 | 1220699-06-8 | ≧98.0% |  |
| PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) | ||||
| 6111110 | Nastorazepide | 209219-38-5 | 98% |  |
| Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative | ||||
| 16122906 | 布瓦西坦 | 357336-20-0 | 98% |  |
| Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a ra | ||||
| 185235 | Trilaciclib (G1T28) | 1374743-00-6 | >98% |  |
| Trilaciclib是一种小分子竞争性细胞周期蛋白依赖性激酶4和6（CDK4 / | ||||
| 188281 | Arimoclomol maleate | 289893-26-1 | 98% |  |
| Arimoclomol，也被称为BRX-220，能够潜在有用的治疗Niemann-Pick疾病C型 | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% |  |
| Anlotinib也被称为AL3818，是一种受体酪氨酸激酶(RTK)抑制剂，具有潜 | ||||
| 19132 | Cilofexor ( GS-9674 ) | 1418274-28-8 | ≧98.0% |  |
| Cilofexor（也称为 GS-9674）是一种非甾体法尼醇 X 受体（FXR）激动剂 | ||||
| 512193 | ITI-214磷酸盐 | 1642303-38-5 | 98% Min. |  |
| ITI-214 is a potent and selective phosphodiesterase 1 (PDE1) inhibitor. As the clinic | ||||